BKM Wealth Management’s iShares US Small Cap Equity Factor ETF SMLF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$749K Sell
8,399
-406
-5% -$33.9K 0.27% 86
2026
Q1
$665K Sell
8,805
-865
-9% -$67.2K 0.24% 91
2025
Q4
$724K Sell
9,670
-13,836
-59% -$1.03M 0.26% 86
2025
Q3
$1.75M Sell
23,506
-1,189
-5% -$85.1K 0.64% 48
2025
Q2
$1.68M Sell
24,695
-3,676
-13% -$233K 0.66% 50
2025
Q1
$1.76M Sell
28,371
-1,352
-5% -$90.9K 0.73% 45
2024
Q4
$2.01M Buy
29,723
+3,102
+12% +$215K 0.82% 35
2024
Q3
$1.77M Buy
26,621
+774
+3% +$49.2K 0.72% 39
2024
Q2
$1.58M Sell
25,847
-255
-1% -$15.6K 0.76% 41
2024
Q1
$1.66M Sell
26,102
-1,173
-4% -$70.1K 0.71% 41
2023
Q4
$1.6M Buy
+27,275
New +$1.44M 0.68% 38

Other funds holding SMLF

BKM Wealth Management's SMLF Position: Q2 2026 in Review

BKM Wealth Management reduced its iShares US Small Cap Equity Factor ETF (SMLF) stake by 4.6% in Q2 2026, selling an estimated $33.9K and leaving 8,399 shares worth $749K. The position accounts for 0.27% of the portfolio, ranked #86.

BKM Wealth Management first reported a position in SMLF in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.01M in Q4 2024. 300 funds tracked by Wall St. Rank hold SMLF as of Q2 2026.

  • BKM Wealth Management held 8,399 shares of iShares US Small Cap Equity Factor ETF worth $749K as of Q2 2026.
  • BKM Wealth Management sold 406 iShares US Small Cap Equity Factor ETF shares in Q2 2026, an estimated $33.9K.
  • iShares US Small Cap Equity Factor ETF made up 0.27% of BKM Wealth Management's portfolio in Q2 2026, its #86 holding.
  • BKM Wealth Management first reported a position in iShares US Small Cap Equity Factor ETF in Q4 2023 and has held it in 11 quarters since.
  • BKM Wealth Management's iShares US Small Cap Equity Factor ETF position peaked at $2.01M in Q4 2024.
  • 300 funds tracked by Wall St. Rank held iShares US Small Cap Equity Factor ETF as of Q2 2026.

Based on BKM Wealth Management's 13F filing for Q2 2026, filed 29 Jul 2026.